Global Neurology Academy

TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
CME/CE
TIME OUT: A Case-Based Deep Dive into the Challenges of ARIA Management
0.50 credits
- James R. Bateman, MD, MPH
- Jerome A. Barakos, MD
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
- B. Joy Snider, MD, PhD
0.50 credits
AI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
AI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
Clinician's Roundtable
AI and EEG Detect Parkinson’s Diagnosis with Near-Perfect Accuracy
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
NeuroFrontiers
Beyond Amyloid and Tau: A Multimarker Approach to Alzheimer's Detection
- Thomas Karikari, PhD
Preventing Alzheimer’s Disease Through Lifestyle Interventions
Preventing Alzheimer’s Disease Through Lifestyle Interventions
NeuroFrontiers
Preventing Alzheimer’s Disease Through Lifestyle Interventions
- Michele Longo, MD
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
NeuroFrontiers
Debunking Misconceptions Regarding the Revised Alzheimer’s Diagnostic Criteria
- Clifford Jack Jr., MD
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
NeuroFrontiers
Beyond the Brain Scan: Blood-Based Biomarker Tests for Alzheimer’s Detection
- Ashley Baker, MSN, PMHNP
- Suzanne Schindler, MD
Diagnosing Myasthenia Gravis: The Impact of Social Media
Diagnosing Myasthenia Gravis: The Impact of Social Media
Clinician's Roundtable
Diagnosing Myasthenia Gravis: The Impact of Social Media
- Ashley Baker, MSN, PMHNP
- Vishnu Pandurangadu, MD/MBA, FACEP
- Pritikanta Paul, MD
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis
NeuroFrontiers
Zilucoplan: A Promising Potential Treatment for Myasthenia Gravis

Medical News

Medical News
Open-World Video Games Found to Boost Mental Well-Being in Postgraduate Students
medicalxpress.com
01/08/2025
Read more
Medical News
Innovative Haptic Belt Shows Promise for Improving Mobility in People With Vision Loss
sciencedaily.com
01/08/2025
Read more
Medical News
Socioeconomic Factors Tied to Brain Lesion Severity in Pediatric MS
medicalxpress.com
01/08/2025
Read more
Medical News
Smartphone App Reduces Opioid Use and Enhances Treatment Retention, Study Finds
news.uthscsa.edu
01/07/2025
Read more

See more news

CME/CE

An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
CME/CE
An Overview of ARIA: A Multidisciplinary Crash Course for Baseline Clinical Needs
0.50 credits
- James R. Bateman, MD, MPH
- Jerome A. Barakos, MD
- Danya Khoujah, MBBS, MEHP, FACEP, FAAEM
- B. Joy Snider, MD, PhD
- Charles P. Vega, MD
0.50 credits
Mastering ARIA Management: Charting the Path in a Virtual Clinic
Mastering ARIA Management: Charting the Path in a Virtual Clinic
CME/CE
Mastering ARIA Management: Charting the Path in a Virtual Clinic
0.25 credits
- James R. Bateman, MD, MPH
0.25 credits
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
CME/CE
Spinal Muscular Atrophy: Optimizing the Management of Adults in the Era of Disease-Modifying Therapies
1.00 credit
- Perry Shieh, MD, PhD
1.00 credit
The Multiple Faces of ATTRv-PN
The Multiple Faces of ATTRv-PN
MinuteCE®
The Multiple Faces of ATTRv-PN
1.00 program credit
- Sami Khella, MD
- Marcia Waddington-Cruz, MD, PhD
1.00 program credit

Clinical Practice

Transforming Schizophrenia Treatment: Advances in Medication and Therapy
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
NeuroFrontiers
Transforming Schizophrenia Treatment: Advances in Medication and Therapy
- Robert Walker, PharmD
- Deanna L. Kelly, PharmD, BCPP
Advancing Schizophrenia Care: Challenges and Promising New Therapies
Advancing Schizophrenia Care: Challenges and Promising New Therapies
NeuroFrontiers
Advancing Schizophrenia Care: Challenges and Promising New Therapies
- Charles Turck, PharmD, BCPS, BCCCP
- Andrew J. Cutler, MD
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
NeuroFrontiers
The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
- John A. Morren, MD, FAAN, FAANEM
Bridging the Gap to Improved Schizophrenia Treatment Options
Bridging the Gap to Improved Schizophrenia Treatment Options
NeuroFrontiers
Bridging the Gap to Improved Schizophrenia Treatment Options

Programs

Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
NeuroFrontiers
Amyloid-Targeted Therapies: A New Era in Alzheimer’s Disease Treatment
- Michele Longo, MD
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
NeuroFrontiers
Schizophrenia and Heart Health: Navigating the Hidden Risk of Sudden Cardiac Death
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
NeuroFrontiers
The BALTAZAR Study: How Caffeine Intake Affects Alzheimer's Biomarkers
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
NeuroFrontiers
MS Treatment Decisions: When to Discontinue Disease-Modifying Therapies
- Brian P. McDonough, MD, FAAFP
- John Corboy, MD, MA